Patrick J. Dalton
Analyst · J.P
Thank you, Rich. As Jim noted earlier, September 2011's quarter was active for us. We invested in 6 new and 8 existing portfolio companies. On a gross basis, these investments totaled $403 million. We also received $313 million of proceeds from select sales and $74 million from prepayments. During the quarter, we continued to execute on our portfolio optimization strategy as we redeployed proceeds from these investment sales into higher yielding assets. Let me take you through some of our specific portfolio activity. Investments were made in the following 6 new portfolio companies: Capsugel, Level 3 Communications, Field Air Corporation [ph], SRA International, TravelPort and U.S. Security Associates. Of these investments, some of the larger investments included $135 million of the senior unsecured mezzanine notes of U.S. Security Associates to support the acquisition of the company by Goldman Sachs Capital Partners. U.S. Security is a leading provider of high-quality customized security solutions for a diverse range of customers across multiple industries. We also invested $30 million in senior notes of SRA International. SRA is a leading provider of IT services and solutions to clients mainly in the federal government. Another $29 million was invested in the senior unsecured and senior floating rate notes of Travelport. Travelport operates a global distribution system to revise aggregation, search and transaction processing services in travel suppliers in online and traditional travel agents. Investments in existing portfolio companies were made in the following 8 names: Alliance Boots, AIC Credit Opportunity Fund, Avaya, Clearwire Communications, Exova, Insight Pharmaceuticals, Intelsat and TL Acquisitions. Of these names, some of the larger investments included $76 million in the senior notes of TL Acquisitions. Regarding this particular investment, we identified an opportunity to sell a more junior security, a discount, and purchase another more senior security, a similar discount, while moving higher up in the capital structure, which we expect will result in a better expected risk-adjusted return. TL Acquisitions is a leading global print and electronic publisher of textbooks, reference materials and other educational resources for higher education, professional training and library reference markets. Regarding Insight Pharmaceuticals, we invested in the recapitalization of the company as they made a strategic acquisition. Notable exits during the quarter included our investment in DSI Renal in conjunction with the sale of the company, which included an $11 million of subordinated debt and $31 million of equity. As a reminder, we made our original investment in DSI Renal in 2006, which ultimately went to a restructuring in early 2010, and we received both preferred and common equity positions in the reorganization. The closing of the sale of DSI Renal this quarter and the strategic acquire concludes our investment and results in a modestly positive IRR on our original investment in 2006. In addition, received a repayment of $8 million on our subordinated debt investment in Angelica, and a full repayment on our $10 million of subordinated debt with Babson-led CLO. Now let me go over some general portfolio statistics at September 30. We continue to be well-diversified by issuer and industry with 69 portfolio companies invested in 30 different industries. The company's total investment portfolio had a fair market value of $2.83 billion, which was comprised of 30% in senior secured loans, 60% in subordinated debt, 1% in preferred equity and 9% in common equity and warrants measured at fair value. Weighted average yield on our overall debt portfolio at our current cost at September 30, 2011, rose to 11.6% as compared to 11.1% at June 30. The weighted average yields on our subordinated debt and senior loan portfolios also rose to 12.6% and 9.4%, respectively, at September 30, 2011, versus 12.3% and 9.2%, respectively, at June 30, 2011. Since the initial public offering of Apollo Investment Corporation in April 2004 and through September 30, 2011, our invested capital has now totaled over $8.5 billion in 161 portfolio companies and transactions with more than 100 different financial sponsors. At September 30, weighted average EBITDA of our portfolio companies continues to exceed $250 million, and the weighted average cash interest coverage of the portfolio remains over 2x. The weighted average risk rating of our total portfolio was 2.4 at September 30, up slightly from 2.3 at June 30 measured at cost. This rated 2.0 measured at fair market value at September 30, 2011, which is unchanged from June 30, 2011. While our September 2011 quarter was an active one, we believe our investment pace will likely remain highly variable and market dependent. Given the continuing uncertainty surrounding the global economies, particularly in Europe, and to a lesser extent, here in the U.S., we believe that the frequency and the depth of market volatility will likely continue for at least the near-term. These types of market conditions could create substantial investment opportunities for Apollo Investment Corporation. We do recognize that our strategy of investing in larger companies comes at a cost of higher NAV volatility in the short run. But it also provides us with what we believe to be enhanced liquidity on our portfolio. We believe that over the long term, in a post Basel III and Dodd-Frank world, there'll be many new types of attractive investment opportunities, while turn of lending institutions like Apollo Investment Corporation expect -- we expect that there will be increasing demand for long-term capital to fill the void of the more traditional sources of capital, which will be forced exit. In closing, we again like to thank all our investors for your continued and long-term support and confidence in us. With that, operator, please open up the call to questions.